Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H15NO2 |
| Molecular Weight | 181.2316 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=CC[C@@H]2CC[C@H]1N2C
InChI
InChIKey=MPSNEAHFGOEKBI-VXNVDRBHSA-N
InChI=1S/C10H15NO2/c1-11-7-3-5-8(10(12)13-2)9(11)6-4-7/h5,7,9H,3-4,6H2,1-2H3/t7-,9-/m1/s1
| Molecular Formula | C10H15NO2 |
| Molecular Weight | 181.2316 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. | 2005-11 |
|
| Two- and three dimensional combinatorial chemistry from multicomponent Grignard reagents. | 2004-07-13 |
|
| Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate. | 2003-12 |
|
| Determination of the dermal penetration of esterom components using microdialysis sampling. | 2003-11 |
|
| Detecting crack and other cocaine use with fastpatches. | 2003-06 |
|
| Studies on in vitro degradation of anhydroecgonine methyl ester (methylecgonidine) in human plasma. | 2002-12-28 |
|
| Examination of postmortem fluids and tissues for the presence of methylecgonidine, ecgonidine, cocaine, and benzoylecgonine using solid-phase extraction and gas chromatography-mass spectrometry. | 2001-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:07:38 GMT 2025
by
admin
on
Mon Mar 31 18:07:38 GMT 2025
|
| Record UNII |
58C337KP3E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
43021-26-7
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY | |||
|
119478
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY | |||
|
58C337KP3E
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY | |||
|
Methylecgonidine
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY | Methylecgonidine is a pyrolysis product formed when crack cocaine is smoked, making this substance a useful biomarker to specifically test for use of crack cocaine, as opposed to powder cocaine which does not form methylecgonidine as a metabolite. | ||
|
m4809
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID20276220
Created by
admin on Mon Mar 31 18:07:38 GMT 2025 , Edited by admin on Mon Mar 31 18:07:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |